ArticleJAAD case reports2025

Immune checkpoint inhibitor-induced dyshidrotic eczema following tremelimumab therapy for hepatocellular carcinoma.

Raphaella Lambert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.